-
261
Nerve Growth Factor Prevents Demyelination, Cell Death and Progression of the Disease in Experimental Allergic Encephalomyelitis
Published 2006-12-01“…Experimental allergic encephalomyelitis (EAE), a demyelinating disease induced in the animals parallels multiple sclerosis in human in several aspects, provides a useful model to investigate multiple sclerosis. …”
Get full text
Article -
262
Guillain-Barré Syndrome with Incomplete Oculomotor Nerve Palsy after Traumatic Brain Injury: Case Report and Literature Review
Published 2023-03-01“…Guillain-Barré syndrome (GBS) is a severe peripheral neuroinflammatory demyelinating disease characterized by symmetrical progressive limb weakness, which can be accompanied by cranial nerve and sensory disturbances. …”
Get full text
Article -
263
Optic Neuritis in Multiple Sclerosis—A Review of Molecular Mechanisms Involved in the Degenerative Process
Published 2022-09-01“…Multiple sclerosis is a central nervous system inflammatory demyelinating disease with a wide range of clinical symptoms, ocular involvement being frequently marked by the presence of optic neuritis (ON). …”
Get full text
Article -
264
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility
Published 2023-01-01“…Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and the association with other autoimmune diseases is well-documented. …”
Get full text
Article -
265
Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
Published 2022-04-01“…Multiple sclerosis (MS) is a chronic neuroinflammatory and demyelinating disease of the central nervous system (CNS), characterised by the infiltration of peripheral immune cells, multifocal white-matter lesions, and neurodegeneration. …”
Get full text
Article -
266
The Cuprizone Model: Dos and Do Nots
Published 2020-03-01“…Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Various pre-clinical models with different specific features of the disease are available to study MS pathogenesis and to develop new therapeutic options. …”
Get full text
Article -
267
Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances
Published 2022-08-01“…Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system that usually affects young adults. …”
Get full text
Article -
268
CADASIL syndrome and demyelination: dual pathology? (a case report)
Published 2022-01-01“…In the presented clinical case, in addition to the genetically proven CADASIL syndrome, the patient had symptoms (awkwardness in her right hand, retrobulbar neuritis), which made us suspect a demyelinating disease. Magnetic resonance imaging revealed foci in the white matter of the brain without the accumulation of contrast and without infratentorial and stem foci. …”
Get full text
Article -
269
Neuromyelitis optica spectrum disorder
Published 2017-09-01“…Over the past 13 years neuromyelitis optica spectrum disorder (NMOSD) has emerged as a discrete form of demyelinating disease of the central nervous system in which antibodies against a water channel found in high concentration on astrocytes are frequently found. …”
Get full text
Article -
270
Heterogeneity in multiple sclerosis: scratching the surface of a complex disease.
Published 2010“…Multiple Sclerosis (MS) is the most common demyelinating disease of the central nervous system. Although the etiology and the pathogenesis of MS has been extensively investigated, no single pathway, reliable biomarker, diagnostic test, or specific treatment have yet been identified for all MS patients. …”
Journal article -
271
Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
Published 2022-08-01“…We sought to explore whether distinct clinical, laboratory, and imaging characteristics along with quantitation of peripheral blood type I interferon (IFN) activity could aid in differentiating between them.Methods: A total of 193 consecutive patients with imaging features suggesting the presence of CNS demyelinating disease with or without relevant clinical manifestations underwent full clinical, laboratory, and imaging evaluation, including testing for specific antibodies against 15 cellular antigens. …”
Get full text
Article -
272
Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird’s Eye View
Published 2018-02-01“…Similar to MS, PML is a demyelinating disease of the CNS, but it is caused by the JC virus. …”
Get full text
Article -
273
Extracellular vesicles in multiple sclerosis: what are they telling us?
Published 2014-03-01“…MS is a central nervous system demyelinating disease characterized by relapsing of symptoms followed by periods of remission. …”
Get full text
Article -
274
Regulation of Polyomavirus Transcription by Viral and Cellular Factors
Published 2020-09-01“…Among several known pathogenic human polyomaviruses, JC polyomavirus (JCPyV) has the potential to cause the demyelinating disease progressive multifocal leukoencephalopathy (PML); BK polyomavirus (BKPyV) can cause nephropathy in kidney transplant recipients, and Merkel cell polyomavirus (MCPyV) is associated with a highly aggressive form of skin cancer, Merkel cell carcinoma (MCC). …”
Get full text
Article -
275
Cognitive Impairment in Multiple Sclerosis
Published 2023-07-01“…Almost three million individuals suffer from multiple sclerosis (MS) throughout the world, a demyelinating disease in the nervous system with increased prevalence over the last five decades, and is now being recognized as one significant etiology of cognitive loss and dementia. …”
Get full text
Article -
276
The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis
Published 2022-07-01“…The etiology of multiple sclerosis (MS), a demyelinating disease affecting the central nervous system (CNS), remains obscure. …”
Get full text
Article -
277
Erythropoietin: New Directions for the Nervous System
Published 2012-09-01“…EPO and its receptor are present in multiple systems of the body and can impact disease progression in the nervous, vascular, and immune systems that ultimately affect disorders such as Alzheimer’s disease, Parkinson’s disease, retinal injury, stroke, and demyelinating disease. EPO relies upon <em>wingless</em> signaling with Wnt1 and an intimate relationship with the pathways of phosphoinositide 3-kinase (PI 3-K), protein kinase B (Akt), and mammalian target of rapamycin (mTOR). …”
Get full text
Article -
278
Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case...
Published 2023-10-01“…Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease caused by reactivation of the human polyomavirus 2 (HPyV-2). …”
Get full text
Article -
279
The Role of Non-Selective TNF Inhibitors in Demyelinating Events
Published 2021-01-01“…Its use in neurological disorders is limited however, due to rare adverse events of demyelination, even in patients without preceding demyelinating disease. We review here the molecular and cellular aspects of this neuroinflammatory process in light of a case of severe monophasic demyelination caused by treatment with infliximab. …”
Get full text
Article -
280
Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients
Published 2020-01-01“…Abstract Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system characterised by incoordination, sensory loss, weakness, changes in bladder capacity and bowel function, fatigue and cognitive impairment, creating a significant socioeconomic burden. …”
Get full text
Article